Literature DB >> 20593502

Impact of pain on health-related quality of life in patients with inflammatory bowel disease.

Anja Schirbel1, Anne Reichert, Stephanie Roll, Daniel C Baumgart, Carsten Büning, Bianca Wittig, Bertram Wiedenmann, Axel Dignass, Andreas Sturm.   

Abstract

AIM: To evaluate intensity, localization and cofactors of pain in Crohn's disease and ulcerative colitis patients in connection with health-related quality of life (HRQOL) and disease activity.
METHODS: We reviewed and analyzed the responses of 334 patients to a specifically designed questionnaire based on the short inflammatory bowel disease questionnaire (SIBDQ) and the German pain questionnaire. Pain intensity, HRQOL, Crohn's disease activity index (CDAI) and colitis activity index (CAI) were correlated and verified on a visual analog scale (VAS).
RESULTS: 87.9% of patients reported pain. Females and males reported comparable pain intensities and HRQOL. Surgery reduced pain in both genders (P = 0.023), whereas HRQOL only improved in females. Interestingly, patients on analgesics reported more pain (P = 0.003) and lower HRQOL (P = 0.039) than patients not on analgesics. A significant correlation was found in UC patients between pain intensity and HRQOL (P = 0.023) and CAI (P = 0.027), and in CD patients between HRQOL and CDAI (P = 0.0001), but not between pain intensity and CDAI (P = 0.35). No correlation was found between patients with low CDAI scores and pain intensity.
CONCLUSION: Most IBD patients suffer from pain and have decreased HRQOL. Our study reinforces the need for effective individualized pain therapy in IBD patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593502      PMCID: PMC2896754          DOI: 10.3748/wjg.v16.i25.3168

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  Low-dose naltrexone therapy improves active Crohn's disease.

Authors:  Jill P Smith; Heather Stock; Sandra Bingaman; David Mauger; Moshe Rogosnitzky; Ian S Zagon
Journal:  Am J Gastroenterol       Date:  2007-01-11       Impact factor: 10.864

2.  Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.

Authors:  Laura T Pizzi; Christine M Weston; Neil I Goldfarb; Deborah Moretti; Nicole Cobb; Jamie B Howell; Anthony Infantolino; Anthony J Dimarino; Sidney Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

3.  Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.

Authors:  Tine Jess; Lene Riis; Ida Vind; Karen Vanessa Winther; Sixten Borg; Vibeke Binder; Ebbe Langholz; Ole Østergaard Thomsen; Pia Munkholm
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

4.  American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

Authors:  Michael Clark; Jean-Frederic Colombel; Brian C Feagan; Richard N Fedorak; Stephen B Hanauer; Michael A Kamm; Lloyd Mayer; Carol Regueiro; Paul Rutgeerts; William J Sandborn; Bruce E Sands; Stefan Schreiber; Stephan Targan; Simon Travis; Severine Vermeire
Journal:  Gastroenterology       Date:  2007-07       Impact factor: 22.682

Review 5.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

6.  Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

Authors:  Ida Vind; Lene Riis; Tine Jess; Elisabeth Knudsen; Natalia Pedersen; Margarita Elkjaer; Inger Bak Andersen; Vibeke Wewer; Peter Nørregaard; Flemming Moesgaard; Flemming Bendtsen; Pia Munkholm
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

7.  Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course.

Authors:  Frank L Wolters; Catelijne Joling; Maurice G Russel; Jildou Sijbrandij; Marion De Bruin; Selwyn Odes; Lene Riis; Pia Munkholm; Paolo Bodini; Barbara Ryan; Colm O'Morain; Ioannis A Mouzas; Epameinondas Tsianos; Severine Vermeire; Estela Monteiro; Charles Limonard; Morten Vatn; Giovanni Fornaciari; Dolores Rodriguez; Wim Groot; Bjørn Moum; Reinhold W Stockbrügger
Journal:  Scand J Gastroenterol       Date:  2007-03       Impact factor: 2.423

8.  Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.

Authors:  Tomm Bernklev; Jørgen Jahnsen; Magne Henriksen; Idar Lygren; Erling Aadland; Jostein Sauar; Tom Schulz; Njål Stray; Morten Vatn; Bjørn Moum
Journal:  Inflamm Bowel Dis       Date:  2006-05       Impact factor: 5.325

9.  A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.

Authors:  Dan Turner; Cynthia H Seow; Gordon R Greenberg; Anne M Griffiths; Mark S Silverberg; A Hillary Steinhart
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-01       Impact factor: 11.382

10.  [Comparison of quality of life in morbidly obese patients and healthy volunteers. A prospective study using the GIQLI questionnaire].

Authors:  T Poghosyan; C Polliand; K Bernard; N Rizk; P Valensi; G Champault
Journal:  J Chir (Paris)       Date:  2007 Mar-Apr
View more
  38 in total

1.  Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.

Authors:  Elodie Picard; Frederic Antonio Carvalho; Francina Agosti; Emmanuel Bourinet; Denis Ardid; Alain Eschalier; Laurence Daulhac; Christophe Mallet
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

2.  Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Authors:  Heba N Iskandar; Benjamin Cassell; Navya Kanuri; C Prakash Gyawali; Alexandra Gutierrez; Themistocles Dassopoulos; Matthew A Ciorba; Gregory S Sayuk
Journal:  J Clin Gastroenterol       Date:  2014 May-Jun       Impact factor: 3.062

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

4.  Symptom clusters in adults with inflammatory bowel disease.

Authors:  Samantha Conley; Deborah D Proctor; Sangchoon Jeon; Robert S Sandler; Nancy S Redeker
Journal:  Res Nurs Health       Date:  2017-08-17       Impact factor: 2.228

5.  Establishing a common metric for self-reported pain: linking BPI Pain Interference and SF-36 Bodily Pain Subscale scores to the PROMIS Pain Interference metric.

Authors:  Karon F Cook; Benjamin D Schalet; Michael A Kallen; Joshua P Rutsohn; David Cella
Journal:  Qual Life Res       Date:  2015-04-18       Impact factor: 4.147

6.  Pain management in patients with inflammatory bowel disease: insights for the clinician.

Authors:  Arvind Iyengar Srinath; Chelsea Walter; Melissa C Newara; Eva M Szigethy
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

7.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

Review 8.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

9.  Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease.

Authors:  Laura Katz; Dean A Tripp; Mark Ropeleski; William Depew; J Curtis Nickel; Stephen Vanner; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2016-03

10.  Pain assessment using the NIH Toolbox.

Authors:  Karon F Cook; Winnie Dunn; James W Griffith; M Tracy Morrison; Jennifer Tanquary; Dory Sabata; David Victorson; Leeanne M Carey; Joy C Macdermid; Brian J Dudgeon; Richard C Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.